Cargando…
Cancer Cell Line Panels Empower Genomics-Based Discovery of Precision Cancer Medicine
Since the first human cancer cell line, HeLa, was established in the early 1950s, there has been a steady increase in the number and tumor type of available cancer cell line models. Cancer cell lines have made significant contributions to the development of various chemotherapeutic agents. Recent ad...
Autores principales: | Kim, Hyun Seok, Sung, Yeo-Jin, Paik, Soonmyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541646/ https://www.ncbi.nlm.nih.gov/pubmed/26256959 http://dx.doi.org/10.3349/ymj.2015.56.5.1186 |
Ejemplares similares
-
Empowering individual trait prediction using interactions for precision medicine
por: Gola, Damian, et al.
Publicado: (2021) -
ACT-05 Present and future of precision-based medicine using cancer genome panels
por: Natsumeda, Manabu, et al.
Publicado: (2020) -
Building towards precision medicine: empowering medical professionals for the next revolution
por: McGrath, Scott, et al.
Publicado: (2016) -
A new tumorgraft panel to accelerate precision medicine in prostate cancer
por: Béraud, Claire, et al.
Publicado: (2023) -
An Improved, Assay Platform Agnostic, Absolute Single Sample Breast Cancer Subtype Classifier
por: Seo, Mi-kyoung, et al.
Publicado: (2020)